The short answer
A reliable clinical effect of Panax ginseng on atorvastatin has not been established in the evidence inspected here. A frequently cited liver-injury case used a mixed product described as Siberian ginseng and milk thistle, so it does not prove this exact botanical interaction.
What this answer covers
Panax ginseng, the Asian ginseng node, with oral atorvastatin. Siberian ginseng, other species and mixed supplements are excluded as exact matches.
- Supplement or preparation
- Asian ginseng
- Medication ingredient
- atorvastatin
Why does the botanical name matter?
The original case report describes Siberian ginseng plus silymarin in someone taking high-dose atorvastatin. Both the mixed supplement and atorvastatin were stopped, and drug levels were not measured. Its broad use of the word ginseng cannot establish which component caused injury or prove a Panax ginseng effect.
What do studies of Panax itself show?
A twelve-person experiment gave Panax ginseng with probe medicines. Midazolam exposure decreased, while fexofenadine was unchanged. Atorvastatin was not tested. Such results suggest that pathways can be affected, but they do not establish an atorvastatin dose change or a uniform direction across products.
Does uncertainty mean there is no risk?
No. It means a specific clinical claim is not yet supported well enough to quantify. Atorvastatin has recognized muscle and liver precautions regardless of supplement use. A new symptom should be assessed on its own merits rather than attributed to or dismissed because of an unconfirmed herb interaction.
What should I show the pharmacist?
Bring the exact botanical species, extract description and complete ingredient list. Mixed products need a review of all components. Continue prescribed treatment while seeking advice; no proven hour-by-hour schedule or self-directed dose adjustment follows from the available Panax evidence.
Evidence and practical considerations
Absorption & effectiveness
A reliable clinical effect of Panax ginseng on atorvastatin has not been established in the evidence inspected here. A frequently cited liver-injury case used a mixed product described as Siberian ginseng and milk thistle, so it does not prove this exact botanical interaction.
- Exact scope
- Panax ginseng, the Asian ginseng node, with oral atorvastatin. Siberian ginseng, other species and mixed supplements are excluded as exact matches. with Exact RxNorm 83367, IN, atorvastatin. LIPITOR contains atorvastatin calcium trihydrate, with strength expressed as atorvastatin active moiety in the label. This is the explicit salt-to-IN bridge.
- Medication form and route
- oral
What remains uncertain
- Exact botanical identity is a material limitation. One mismatched mixed-product case and indirect probe-drug research do not establish Panax-atorvastatin efficacy or toxicity.
Factors that may matter: Exact preparation, dose, other medicines and baseline clinical condition matter..
Read the supporting source summaries
Source 1: original case report with identity mismatch
bpspubs.onlinelibrary.wiley.com · Source check Sep 10, 2026
Population: One 82-year-old man taking atorvastatin 80 mg.
Liver tests improved after both the supplement and atorvastatin stopped.
How this applies: Restricted to the exact identities and conditions described in this article.
Wrong/uncertain botanical for Panax ginseng, mixed product, no drug levels, and simultaneous withdrawal. Excluded as direct Panax-atorvastatin proof.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Twelve healthy participants.
Midazolam AUC fell to 0.66 of baseline; fexofenadine pharmacokinetics were unaltered.
How this applies: Restricted to the exact identities and conditions described in this article.
Atorvastatin was not administered. A probe result does not establish the direction or size of an atorvastatin interaction.
Source 3: regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral atorvastatin.
Provides grapefruit and lipid-modifying niacin precautions, symptom monitoring and once-daily administration with or without food.
How this applies: Restricted to the exact identities and conditions described in this article.
Absence of an ingredient from the label is not a negative interaction study. No pectin, oat bran or Panax-specific human effect size is supplied.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original-source assessment and consumer article prepared; exact claim dispositions, neutral findings and preparation limits recorded. | |
| Clinical sign-off is pending and no publication approval is asserted. | |
| Research summary published |
Article revision: a261bb62db05a5ad
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.